D-0095-2021 Class II Terminated

Recalled by Milbar Laboratories, Inc. — East Haven, CT

FDA drug recall D-0095-2021 was initiated by Milbar Laboratories, Inc. on Oct 9, 2020 and is designated Class II. Reason for recall: GMP Deviations The recall status is terminated (terminated Jan 4, 2023). Affected quantity: 927 tubes.

Recall details

Product Type
Drugs
Report Date
Nov 25, 2020
Initiation Date
Oct 9, 2020
Termination Date
Jan 4, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
927 tubes

Product description

DCL Clear Skin Anti-Blemish Hydrator (2% Salicylic Acid), 50ml/1.7 fl. oz, Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA

Reason for recall

GMP Deviations

Distribution pattern

Product was distributed throughout the United States, including Puerto Rico and internationally.

Code information

Lot #: FX432-5, Exp. Date June-21

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0095-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0095-2021. Report a data issue: hello@regdatalab.com.